We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Doc Admits Letting Aegerion See Patient Data, Target Teens

Law360, Boston (February 28, 2018, 6:00 PM EST) -- A pediatric cardiologist helped Aegerion Pharmaceuticals Inc. target dozens of his teenage patients with heart conditions for an expensive medication approved only to treat an ultra-rare disease that none of them...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.